PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Centenial Surgical Suture Ltd reported strong Q3 FY26 results with revenue from operations of ₹1,486.42 lakhs, up 21.9% from ₹1,219.88 lakhs in Q3 FY25. The company swung to a profit of ₹14.70 lakhs in Q3 FY26 from a loss of ₹84.77 lakhs in the same quarter last year, with EPS improving to ₹0.40 from (₹2.30). For nine months ended December 31, 2025, revenue grew modestly to ₹4,125.53 lakhs versus ₹4,020.85 lakhs in the prior year period, with a profit of ₹10.88 lakhs compared to a loss of ₹28.02 lakhs. EBITDA margin expanded meaningfully to around 10.6% in Q3 FY26 from about 6.2% in Q3 FY25, driven by better operating leverage and lower finance costs. The statutory auditor issued an unqualified limited review report with no qualifications or emphasis of matter.
A sharp year-on-year turnaround to profitability, strong revenue growth, and improving margins are positive signals for shareholders, though the absolute profit remains small and dependent on continued revenue momentum.